December 17, 2012

Pharmaceutical Marketing and The N.J. Consumer Fraud Act

Florham Park partner Ken Wilbur wrote an article for the New Jersey Law Journal titled, “Pharmaceutical Marketing and The N.J. Consumer Fraud Act.”

Ken notes that while consumer protection statutes, if applied without consideration of interests other than consumer protection, can cross the dividing line between effective and oppressive government action.  His article discusses safeguards in the New Jersey Consumer Fraud Act that should prevent the Act from being used, like similar statutes in other states, to penalize pharmaceutical marketing for its mere potential to be misunderstood.  It also explains how the Supreme Court’s recent decision in United States v. Alvarez should also preclude application of the Act in this manner.

Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.